| EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, J Bellmunt, M Bolla, E Briers, MG Cumberbatch, M De Santis, ... European urology 71 (4), 618-629, 2017 | 3745 | 2017 |
| EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013 A Heidenreich, PJ Bastian, J Bellmunt, M Bolla, S Joniau, T van der Kwast, ... European urology 65 (1), 124-137, 2014 | 2472 | 2014 |
| EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease A Heidenreich, J Bellmunt, M Bolla, S Joniau, M Mason, V Matveev, ... European urology 59 (1), 61-71, 2011 | 1981 | 2011 |
| EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer A Heidenreich, PJ Bastian, J Bellmunt, M Bolla, S Joniau, T van der Kwast, ... European urology 65 (2), 467-479, 2014 | 1917 | 2014 |
| EAU guidelines on prostate cancer A Heidenreich, G Aus, M Bolla, S Joniau, VB Matveev, HP Schmid, ... European urology 53 (1), 68-80, 2008 | 1875 | 2008 |
| EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer P Cornford, J Bellmunt, M Bolla, E Briers, M De Santis, T Gross, AM Henry, ... European urology 71 (4), 630-642, 2017 | 1607 | 2017 |
| Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial P Ost, D Reynders, K Decaestecker, V Fonteyne, N Lumen, A De Bruycker, ... Journal of Clinical Oncology 36 (5), 446-453, 2018 | 1200 | 2018 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 831 | 2018 |
| EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer N Mottet, J Bellmunt, M Bolla, S Joniau, M Mason, V Matveev, HP Schmid, ... Actas Urológicas Espaņolas (English Edition) 35 (10), 565-579, 2011 | 742 | 2011 |
| Guidelines on A Heidenreich, M Bolla, S Joniau, MD Mason, V Matveev, N Mottet, ... Update, 2007 | 686 | 2007 |
| Guidelines on prostate cancer N Mottet, J Bellmunt, E Briers, RCN Van den Bergh, M Bolla, ... European Association of Urology 56, e137, 2015 | 614 | 2015 |
| The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review N Fossati, PPM Willemse, T Van den Broeck, RCN van den Bergh, ... European urology 72 (1), 84-109, 2017 | 512 | 2017 |
| Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer JV Swinnen, T Roskams, S Joniau, H Van Poppel, R Oyen, L Baert, ... International journal of cancer 98 (1), 19-22, 2002 | 434 | 2002 |
| What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the … PC Moldovan, T Van den Broeck, R Sylvester, L Marconi, J Bellmunt, ... European urology 72 (2), 250-266, 2017 | 401 | 2017 |
| EAU–ESTRO–ESUR–SIOG guidelines on prostate cancer N Mottet, J Bellmunt, E Briers, M Bolla, L Bourke, P Cornford, M De Santis, ... European Association of Urology, 2018 | 380 | 2018 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 362 | 2021 |
| Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery K Bensalah, AJ Pantuck, N Rioux-Leclercq, R Thuret, F Montorsi, ... European urology 57 (3), 466-473, 2010 | 341 | 2010 |
| Radiotherapy for renal-cell carcinoma G De Meerleer, V Khoo, B Escudier, S Joniau, A Bossi, P Ost, A Briganti, ... The Lancet Oncology 15 (4), e170-e177, 2014 | 311 | 2014 |
| Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology JP Droz, L Balducci, M Bolla, M Emberton, JM Fitzpatrick, S Joniau, ... BJU international 106 (4), 462-469, 2010 | 295 | 2010 |
| Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review M Lardas, M Liew, RC van den Bergh, M De Santis, J Bellmunt, ... European urology 72 (6), 869-885, 2017 | 279 | 2017 |
Alberto BrigantiVita-Salute San Raffaele University, Milan, ItalyGeverifieerd e-mailadres voor hsr.it
